Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Experimental Ultraviolet Induced Apoptosis in Explanted Human Lens Epithelial Cells Enriched With Caffeine: a Pilot Study

NCT03534973 is registered in ClinicalTrials.gov with Vienna Institute for Research in Ocular Surgery as lead sponsor.

NCT NCT03534973
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03534973 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Experimental Ultraviolet Induced Apoptosis in Explanted Human Lens Epithelial Cells Enriched With Caffeine: a Pilot Study
Lead sponsor
Vienna Institute for Research in Ocular Surgery
Phase
Not applicable
Overall status
Unknown status
Start date
April 17, 2018
Completion date
January 1, 2020
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cataract